跳至主要内容
临床试验/NL-OMON43988
NL-OMON43988已完成不适用

Targeted vessel ablation of type 3 uterine fibroids with magnetic resonance guided high intensity focused ultrasound - HIFU-TVA of type 3 fibroids

niversitair Medisch Centrum Utrecht0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Women, aged at least 18 years;
  • - Able to give informed consent;
  • - A type 3 uterine fibroid;
  • - Sufficient physical condition to undergo deep sedation;
  • - Waist circumference that allows positioning on the HIFU table top inside the MR bore.

排除标准

  • - Contra-indication for MRI scanning according to the hospital guidelines;
  • - Contra-indication to injection of gadolinium-based contrast agent, including known prior allergic reaction to any contrast agent, and renal failure (GFR < 30 mL/min/1.73 m2);
  • - Surgical clips or considerable scar tissue in the HIFU beam path;
  • - A total of more than ten fibroids;
  • - Post- or peri-menopausal status;
  • - Fibroid size >10 cm in diameter;
  • - Patient has an active pelvic infection;
  • - Patient has an undiagnosed pelvic mass outside the uterus;
  • - Patient who is not able to tolerate the required stationary prone position during treatment.

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验